Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
Ontology highlight
ABSTRACT: Kidney transplant recipients (KTRs) have been identified as a population at increased risk for severe SARS-CoV-2 infection outcomes. This study focused on understanding the immune response of KTRs post-vaccination, specifically examining both serological and cellular responses to the SARS-CoV-2 vaccine. Thirteen individuals, including seven KTRs and six healthy donors, were evaluated for antibody levels and T cell responses post-vaccination. The study revealed that KTRs had significantly lower serological responses, including reduced anti-receptor binding domain (RBD) binding antibodies and neutralizing antibodies against the Wuhan, Delta, and Omicron BA.2 strains. Additionally, KTRs demonstrated weaker CD8 T cell cytotoxic responses and lower Th1 cytokine secretion, particularly IFN-γ, af
SUBMITTER: Cheng Y-L
PROVIDER: S-EPMC11237705 | biostudies-literature | 2024 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA